Task: Answer the multiple-choice question.
Question: Which compound exhibits a 13.013\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a) N#Cc1ccc(-c2ccc(F)cc2)nc1Sc1ccccc1
b) O=C(CC1(O)C(=O)c2ccccc2C1=O)c1ccccc1
c) CCn1c(=S)[nH]c2sc3c(c2c1=O)CCCCC3
Answer: c. CCn1c(=S)[nH]c2sc3c(c2c1=O)CCCCC3
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1c(=S)[nH]c2sc3c(c2c1=O)CCCCC3
CCn1c(=S)[nH]c2sc3c(c2c1=O)CCCCC3
4-ethyl-5-sulfanylidene-8-thia-4,6-diazatricyclo[7.5.0.02,7]tetradeca-1(9),2(7)-dien-3-one